Literature DB >> 34046222

Feasibility and potential advantages using VMAT in SRS metastasis treatments.

Maria Jose Perez-Calatayud1, Antonio Vicente Menendez2, Francisco Javier Celada-Alvarez3, Antonio Jose Conde-Moreno3, Mariola Bernisz3, Françoise Lliso3, Vicente Carmona3, Jose Gimeno-Olmos3, Carlos Botella2, Jose Perez-Calatayud3,4.   

Abstract

BACKGROUND: Utilization of stereotactic radiosurgery (SRS) for brain metastases (BM) has become the technique of choice as opposed to whole brain radiation therapy (WBRT). The aim of this work is to evaluate the feasibility and potential benefits in terms of normal tissue (NT) and dose escalation of volumetric modulated arc therapy (VMAT) in SRS metastasis treatment. A VMAT optimization procedure has therefore been developed for internal dose scaling which minimizes planner dependence.
MATERIALS AND METHODS: Five patient-plans incorporating treatment with frame-based SRS with dynamic conformal arc technique (DA) were re-planned for VMAT. The lesions selected were between 4-6 cm3. The same geometry used in the DA plans was maintained for the VMAT cases. A VMAT planning procedure was performed attempting to scale the dose in inner auxiliary volumes, and to explore the potential for dose scaling with this technique. Comparison of dose-volume histogram (DVH) parameters were obtained.
RESULTS: VMAT allows a superior NT sparing plus conformity and dose scaling using the auxiliary volumes. The VMAT results were significantly superior in NT sparing, improving both the V10 and V12 values in all cases, with a 2-3 cm3 saving. In addition, VMAT improves the dose coverage D95 by about 0.5 Gy. The objective of dose escalation was achieved with VMAT with an increment of the Dmean and the Dmedian of about 2 Gy.
CONCLUSIONS: This work shows a benefit of VMAT in SRS treatment with significant NT sparing. A VMAT optimization procedure, based on auxiliary inner volumes, has been developed, enabling internal dose escalation.
© 2021 Greater Poland Cancer Centre.

Entities:  

Keywords:  SRS; VMAT; clinical dosimetry; metastasis; radiotherapy

Year:  2021        PMID: 34046222      PMCID: PMC8149131          DOI: 10.5603/RPOR.a2021.0019

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  29 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases.

Authors:  May Tsao; Wei Xu; Arjun Sahgal
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

3.  The use of RapidArc volumetric-modulated arc therapy to deliver stereotactic radiosurgery and stereotactic body radiotherapy to intracranial and extracranial targets.

Authors:  Dante E Roa; Daniel C Schiffner; Juying Zhang; Salam N Dietrich; Jeffrey V Kuo; Jason Wong; Nilam S Ramsinghani; Muthana S A L Al-Ghazi
Journal:  Med Dosim       Date:  2012-02-24       Impact factor: 1.482

4.  Prospective assessment of mask versus frame fixation during Gamma Knife treatment for brain metastases.

Authors:  Mario A Grimm; Ulrich Köppen; Florian Stieler; Grit Welzel; Arne Mathias Ruder; Martin Polednik; Frederik Wenz; Sabine K Mai; Frank A Giordano
Journal:  Radiother Oncol       Date:  2020-05-19       Impact factor: 6.280

5.  Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.

Authors:  Brian J Blonigen; Ryan D Steinmetz; Linda Levin; Michael A Lamba; Ronald E Warnick; John C Breneman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-23       Impact factor: 7.038

Review 6.  The management of brain metastases.

Authors:  Roy A Patchell
Journal:  Cancer Treat Rev       Date:  2003-12       Impact factor: 12.111

7.  Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.

Authors:  Giuseppe Minniti; Enrico Clarke; Gaetano Lanzetta; Mattia Falchetto Osti; Guido Trasimeni; Alessandro Bozzao; Andrea Romano; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2011-05-15       Impact factor: 3.481

Review 8.  Radiation therapy for older patients with brain tumors.

Authors:  Giuseppe Minniti; Andrea Riccardo Filippi; Mattia Falchetto Osti; Umberto Ricardi
Journal:  Radiat Oncol       Date:  2017-06-19       Impact factor: 3.481

9.  Fractionated stereotactic radiation therapy for intact brain metastases.

Authors:  Samuel R Marcrom; Andrew M McDonald; Jonathan W Thompson; Richard A Popple; Kristen O Riley; James M Markert; Christopher D Willey; Markus Bredel; John B Fiveash
Journal:  Adv Radiat Oncol       Date:  2017-07-19

Review 10.  Modern management for brain metastasis patients using stereotactic radiosurgery: literature review and the authors' gamma knife treatment experiences.

Authors:  Yoshinori Higuchi; Masaaki Yamamoto; Toru Serizawa; Hitoshi Aiyama; Yasunori Sato; Bierta E Barfod
Journal:  Cancer Manag Res       Date:  2018-07-05       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.